Tremfya® (Guselkumab) Studies Underscore Its Potential to Be the Only Il-23 Inhibitor to Offer Both Subcutaneous and Intravenous Induction
Tremfya®(古塞魯單抗)的研究強調了其具有皮下和靜脈誘導作用,有望成爲唯一同時提供兩種誘導方式的IL-23抑制劑。
Tremfya® (Guselkumab) Studies Underscore Its Potential to Be the Only Il-23 Inhibitor to Offer Both Subcutaneous and Intravenous Induction
Tremfya®(古塞魯單抗)的研究強調了其具有皮下和靜脈誘導作用,有望成爲唯一同時提供兩種誘導方式的IL-23抑制劑。
譯文內容由第三人軟體翻譯。